Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2022

Open Access 08-03-2022 | Gastroesophageal Reflux Disease | Review

Endoscopic Management of GERD

Authors: David P. Lee, Kenneth J. Chang

Published in: Digestive Diseases and Sciences | Issue 5/2022

Login to get access

Abstract

Gastroesophageal reflux disease (GERD) has consistently been the most frequently diagnosed gastrointestinal malady in the USA. The mainstay of therapy has traditionally been medical management, including lifestyle and dietary modifications as well as antacid medications. In those patients found to be refractory to medical management or with a contraindication to medications, the next step up has been surgical anti-reflux procedures. Recently, though innovative advancements in therapeutic endoscopy have created numerous options for the endoscopic management of GERD, in this review, we discuss the various endoscopic therapy options, as well as suggested strategies we use to recommend the most appropriate therapy for patients.
Literature
1.
Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 2018;154:267–276.PubMedCrossRef
2.
3.
4.
Fry LC, Monkemuller K, Malfertheiner P. Systematic review: Endoluminal therapy for gastro-oesophageal reflux disease: Evidence from clinical trials. Eur J Gastroenterol Hepatol 2007;19:1125–1139.PubMedCrossRef
5.
Triadafilopoulos G. Stretta: An effective, minimally invasive treatment for gastroesophageal reflux disease. Am J Med 2003;115:192S–200S.PubMedCrossRef
6.
7.
Utley DS, Kim M, Vierra MA et al. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: A porcine model. Gastrointest Endosc 2000;52:81–86.PubMedCrossRef
8.
Kim MS, Holloway RH, Dent J et al. Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc 2003;57:17–22.PubMedCrossRef
9.
Arts J, Bisschops R, Blondeau K et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol 2012;107:222–230.PubMedCrossRef
10.
Ayazi S, Tamhankar A, DeMeester SR et al. The impact of gastric distension on the lower esophageal sphincter and its exposure to acid gastric juice. Ann Surg 2010;252:57–62.PubMedCrossRef
11.
Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: A systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech 2012;22:283–288.PubMedCrossRef
12.
Chen D, Barber C, McLoughlin P et al. Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. Br J Surg 2009;96:128–136.PubMedCrossRef
13.
Liu HF, Zhang JG, Li J et al. Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery. World J Gastroenterol 2011;17:4429–4433.PubMedCrossRefPubMedCentral
14.
Gersin KRF. The Stretta procedure: Review of catheter and technique evolution, efficacy and complications 2 years after introduction. Surg Endosc 2002;16:199.
15.
Corley DA, Katz P, Wo JM et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: A randomized, sham-controlled trial. Gastroenterology 2003;125:668–676.PubMedCrossRef
16.
Coron E, Sebille V, Cadiot G et al. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 2008;28:1147–1158.PubMedCrossRef
17.
Aziz AM, El-Khayat HR, Sadek A et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc 2010;24:818–825.PubMedCrossRef
18.
Triadafilopoulos G, DiBaise JK, Nostrant TT et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the US open label trial. Gastrointest Endosc 2002;55:149–56.PubMedCrossRef
19.
Dughera L, Navino M, Cassolino P et al. Long-term results of radiofrequency energy delivery for the treatment of GERD: Results of a prospective 48-month study. Diagn Ther Endosc 2011;2011:507157.PubMedCrossRefPubMedCentral
20.
Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc 2007;65:367–372.PubMedCrossRef
21.
Reymunde A, Santiago N. Long-term results of radiofrequency energy delivery for the treatment of GERD: Sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up. Gastrointest Endosc 2007;65:361–366.PubMedCrossRef
22.
Dughera L, Rotondano G, De Cento M et al. Durability of Stretta radiofrequency treatment for GERD: Results of an 8-year follow-up. Gastroenterol Res Pract 2014;2014:531907.PubMedCrossRefPubMedCentral
23.
Noar M, Squires P, Noar E et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: A decade later. Surg Endosc 2014;28:2323–2333.PubMedCrossRef
24.
Jobe BA, O’Rourke RW, McMahon BP et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: The anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg 2008;248:69–76.PubMedCrossRef
25.
Rinsma NF, Smeets FG, Bruls DW et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc 2014;28:941–949.PubMedCrossRef
26.
Nguyen NT, Chinn J, Chang K. Collaboration between GI surgery & gastroenterology improves understanding of the optimal antireflux valve-the omega flap valve. Surg Endosc 2021.
27.
Mittal RK, Zifan A, Kumar D et al. Functional morphology of the lower esophageal sphincter and crural diaphragm determined by three-dimensional high-resolution esophago-gastric junction pressure profile and CT imaging. Am J Physiol Gastrointest Liver Physiol 2017;313:G212–G219.PubMedCrossRefPubMedCentral
28.
Yassi R, Cheng LK, Rajagopal V et al. Modeling of the mechanical function of the human gastroesophageal junction using an anatomically realistic three-dimensional model. J Biomech 2009;42:1604–1609.PubMedCrossRefPubMedCentral
29.
Ashfaq A, Rhee HK, Harold KL. Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication. World J Gastroenterol 2014;20:17115–17119.PubMedCrossRefPubMedCentral
30.
Barnes WE, Hoddinott KM, Mundy S et al. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 2011;18:119–129.PubMedCrossRef
31.
Bell RC, Fox MA, Barnes WE et al. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication. Surg Endosc 2014;28:2949–2958.PubMedCrossRefPubMedCentral
32.
Bell RC, Freeman KD. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc 2011;25:1975–1984.PubMedCrossRef
33.
Chimukangara M, Jalilvand AD, Melvin WS et al. Long-term reported outcomes of transoral incisionless fundoplication: An 8-year cohort study. Surg Endosc 2019;33:1304–1309.PubMedCrossRef
34.
Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 2011;202:740–6; discussion 746–7.
35.
36.
Narsule CK, Burch MA, Ebright MI et al. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: Initial experience. J Thorac Cardiovasc Surg 2012;143:228–234.PubMedCrossRef
37.
Stefanidis G, Viazis N, Kotsikoros N et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus 2017;30:1–8.PubMed
38.
Testoni PA, Corsetti M, Di Pietro S et al. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients. World J Surg 2010;34:750–757.PubMedCrossRef
39.
Testoni PA, Testoni S, Mazzoleni G et al. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: A prospective single-center study. Surg Endosc 2015;29:2770–2780.PubMedCrossRef
40.
Trad KS, Barnes WE, Prevou ER et al. The TEMPO Trial at 5 years: Transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018;25:149–157.PubMedCrossRefPubMedCentral
41.
Wilson EB, Barnes WE, Mavrelis PG et al. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech 2014;24:36–46.PubMedCrossRef
42.
Trad KS, Barnes WE, Simoni G et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: The TEMPO Randomized Clinical Trial. Surg Innov 2015;22:26–40.PubMedCrossRefPubMedCentral
43.
Hunter JG, Kahrilas PJ, Bell RC et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology 2015;148:324-333 e5.PubMedCrossRef
44.
Hakansson B, Montgomery M, Cadiere GB et al. Randomised clinical trial: Transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015;42:1261–70.PubMedCrossRef
45.
Gerson L, Stouch B, Lobontiu A. Transoral incisionless fundoplication (TIF 2.0): A meta-analysis of three randomized, controlled clinical trials. Chirurgia (Bucur) 2018;113:173–184.CrossRef
46.
Testoni PA, Distefano G, Mazzoleni G et al. Transoral incisionless fundoplication with Esophyx (TIF 2.0) for gastro-esophageal reflux disease: Three to ten year outcomes in a prospective observational single-center study. Gastrointest Endosc. 2018;87:AB 262-AB 263.CrossRef
47.
Choi AY, Roccato MK, Samarasena JB et al. Novel interdisciplinary approach to GERD: Concomitant laparoscopic hiatal hernia repair with transoral incisionless fundoplication. J Am Coll Surg 2021;232:309–318.PubMedCrossRef
48.
49.
Smith CD, Ganz RA, Lipham JC et al. Lower esophageal sphincter augmentation for gastroesophageal reflux disease: The safety of a modern implant. J Laparoendosc Adv Surg Tech A 2017;27:586–591.PubMedCrossRef
50.
Galmiche JP, Hatlebakk J, Attwood S et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: The LOTUS randomized clinical trial. JAMA 2011;305:1969–1977.PubMedCrossRef
51.
Schlottmann F, Luckett DJ, Fine J et al. Laparoscopic Heller Myotomy versus peroral endoscopic myotomy (POEM) for achalasia: A systematic review and meta-analysis. Ann Surg 2018;267:451–460.PubMedCrossRef
52.
Awaiz A, Yunus RM, Khan S et al. Systematic review and meta-analysis of perioperative outcomes of peroral endoscopic myotomy (POEM) and laparoscopic Heller Myotomy (LHM) for achalasia. Surg Laparosc Endosc Percutan Tech 2017;27:123–131.PubMedCrossRef
53.
Zhang Y, Wang H, Chen X et al. Per-oral endoscopic myotomy versus laparoscopic Heller Myotomy for achalasia: A meta-analysis of nonrandomized comparative studies. Medicine (Baltimore) 2016;95:e2736.CrossRef
54.
Marano L, Pallabazzer G, Solito B et al. Surgery or peroral esophageal myotomy for achalasia: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3001.CrossRef
55.
Repici A, Fuccio L, Maselli R et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: A systematic review with meta-analysis. Gastrointest Endosc 2018;87:934-943 e18.PubMedCrossRef
56.
Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: A prospective randomized double-blind clinical trial. Ann Surg. 2004;240:405–12; discussion 412–5.
57.
Tyberg A, Choi A, Gaidhane M et al. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: A crucial addition to our arsenal. Endosc Int Open 2018;6:E549–E552.PubMedCrossRefPubMedCentral
58.
Chang KJ. Endoscopic foregut surgery and interventions: The future is now. The state-of-the-art and my personal journey. World J Gastroenterol 2019;25:1–41.PubMedCrossRefPubMedCentral
59.
Bou Daher H, Sharara AI. Gastroesophageal reflux disease, obesity and laparoscopic sleeve gastrectomy: The burning questions. World J Gastroenterol 2019;25:4805–4813.PubMedCrossRefPubMedCentral
60.
Gu L, Chen B, Du N et al. Relationship between bariatric surgery and gastroesophageal reflux disease: A systematic review and meta-analysis. Obes Surg 2019;29:4105–4113.PubMedCrossRef
61.
Popescu AL, Ionita-Radu F, Jinga M et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. Rom J Intern Med 2018;56:227–232.PubMed
62.
63.
Hathorn KE, Chan WW, Lo WK. Role of gastroesophageal reflux disease in lung transplantation. World J Transpl 2017;7:103–116.CrossRef
64.
Wood RK. Esophageal dysmotility, gastro-esophageal reflux disease, and lung transplantation: What is the evidence? Curr Gastroenterol Rep 2015;17:48.PubMedCrossRef
65.
66.
Pleskow D, Rothstein R, Lo S et al. Endoscopic full-thickness plication for the treatment of GERD: A multicenter trial. Gastrointest Endosc 2004;59:163–171.PubMedCrossRef
67.
Pleskow D, Rothstein R, Lo S et al. Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial. Gastrointest Endosc 2005;61:643–649.PubMedCrossRef
68.
Pleskow D, Rothstein R, Kozarek R et al. Endoscopic full-thickness plication for the treatment of GERD: Long-term multicenter results. Surg Endosc 2007;21:439–444.PubMedCrossRef
69.
Pleskow D, Rothstein R, Kozarek R et al. Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results. Surg Endosc 2008;22:326–332.PubMedCrossRef
70.
Han J, Chin M, Fortinsky KJ et al. Endoscopic augmentation of gastroesophageal junction using a full-thickness endoscopic suturing device. Endosc Int Open 2018;6:E1120–E1125.PubMedCrossRefPubMedCentral
71.
Fortinsky KJ, Shimizu T, Chin M et al. Mucosal ablation and suturing at the esophagogastric junction (MASE): A novel procedure for the management of patients with gastroesophageal reflux disease. Gastroinest Endosc 2018;87:AB552.CrossRef
72.
Inoue H, Ito H, Ikeda H et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: A pilot study. Ann Gastroenterol 2014;27:346–351.PubMedPubMedCentral
73.
Ota K, Takeuchi T, Harada S et al. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease. Scand J Gastroenterol 2014;49:1409–1413.PubMedCrossRef
74.
Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy (ARMS) for GERD: Feasibility, safety, and technique (with video). J Gastrointest Surg 2019;23:1274–1278.PubMedCrossRef
75.
Monino L, Gonzalez JM, Vitton V et al. Anti-reflux mucosectomy with band ligation in the treatment of refractory gastroesophageal reflux disease. Endoscopy 2019;51:E215–E216.PubMedCrossRef
76.
Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy (ARMS) for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video). Dig Endosc 2020;32:745–752.PubMedCrossRef
77.
Yoo IK, Ko WJ, Kim HS et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: A prospective feasibility study. Surg Endosc 2020;34:1124–1131.PubMedCrossRef
78.
Benias PC, D’Souza L, Lan G et al. Initial experience with a novel resection and plication (RAP) method for acid reflux: A pilot study. Endosc Int Open 2018;6:E443–E449.PubMedCrossRefPubMedCentral
79.
Sowa P, Ortizo R, Samarasena J, et al. Resection and plication (RAP): A novel procedure for the management of gastroesophageal reflux disease. Gastroinest Endosc. 2020;XX:Abstract submitted.
Metadata
Title
Endoscopic Management of GERD
Authors
David P. Lee
Kenneth J. Chang
Publication date
08-03-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07390-2

Other articles of this Issue 5/2022

Digestive Diseases and Sciences 5/2022 Go to the issue

Review

Lumen Apposition: A Changing Landscape in Therapeutic Endoscopy

Review

Revision Bariatric Procedures and Management of Complications from Bariatric Surgery

Original Article

Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis

Review

Endoscopic Management of Barrett's Esophagus

Review

Primary Bariatric Procedures

Original Article

Correlation of Probe-Based Confocal Laser Endomicroscopy (pCLE) and Mucosal Integrity Testing (MIT) with Epithelial Barrier Function and Presence of Gastroesophageal Reflux Disease (GERD)

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits